A phase II study of a human anti-PDGFR alpha monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors

Wagner, A. J.; Kindler, H.; Gelderblom, H.; Schoffski, P.; Bauer, S.; Hohenberger, P.; Kopp, H. -G.; Lopez-Martin, J. A.; Peeters, M.; Reichardt, P.; Qin, A.; Nippgen, J.; Ilaria, R. L.; Rutkowski, P.

dc.contributor.author	Kopp, Hans-Georg
dc.date.accessioned	2018-04-24T08:16:53Z
dc.date.available	2018-04-24T08:16:53Z
dc.date.issued	2017
dc.identifier.issn	1569-8041
dc.identifier.uri	http://hdl.handle.net/10900/81603
dc.language.iso	en	de_DE
dc.publisher	Oxford Univ Press	de_DE
dc.relation.uri	http://dx.doi.org/10.1093/annonc/mdw659	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	A phase II study of a human anti-PDGFR alpha monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors	de_DE
dc.type	Article	de_DE
utue.quellen.id	20170815222223_01511
utue.publikation.seiten	541-546	de_DE
utue.personen.roh	Wagner, A. J.
utue.personen.roh	Kindler, H.
utue.personen.roh	Gelderblom, H.
utue.personen.roh	Schoffski, P.
utue.personen.roh	Bauer, S.
utue.personen.roh	Hohenberger, P.
utue.personen.roh	Kopp, H. -G.
utue.personen.roh	Lopez-Martin, J. A.
utue.personen.roh	Peeters, M.
utue.personen.roh	Reichardt, P.
utue.personen.roh	Qin, A.
utue.personen.roh	Nippgen, J.
utue.personen.roh	Ilaria, R. L.
utue.personen.roh	Rutkowski, P.
dcterms.isPartOf.ZSTitelID	Annals of Oncology	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	28	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE